CanSino

After AstraZeneca mRNA deal, CanSino eyes other production partnerships
Fierce Pharma
Tue, 09/5/23 - 11:30 am
CanSino
MRNA
AstraZeneca
vaccines
CanSino reaps $748M windfall from Shanghai IPO — as it warns Covid-19 vaccine won't be a huge money maker
Endpoints
Thu, 08/13/20 - 09:54 am
CanSino
Shanghai
IPOs
vaccines
COVID-19